| NAME |
ADALIMUMAB-ATTO 40MG/0.8ML INJ,SYRINGE |
| VA GENERIC NAME |
ADALIMUMAB-ATTO |
| DOSAGE FORM |
INJ,SOLN |
| FDA MED GUIDE |
Adalimumab-atto_(Amjevita)_(2023).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| PRIMARY EPA CODE |
D001 |
| WASTE SORT CODE |
BKC |
| DOT SHIPPING CODE |
Flammable liquids, n.o.s.
|
| FORMULARY DESIGNATOR TEXT |
|
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
40 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| UNITS |
MG/0.8ML |
| NATIONAL FORMULARY NAME |
ADALIMUMAB-ATTO INJ,SOLN |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2023-02-09 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
ADALIMUMAB-ATTO 40MG/0.8ML INJ SYR |
| VA PRODUCT IDENTIFIER |
A2151 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
SYR |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4042012 |
| EFFECTIVE DATE/TIME |
-
- 2023-02-09 00:00:00
- STATUS: ACTIVE
|
